Clinical Trial Update: Women in Dual With Dolutegravir [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on women using dolutegravir in dual therapy for HIV infection; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: HIV Infections | Phase 3 | Status: UNKNOWN